Advertisement

European Journal of Nutrition

, Volume 46, Issue 6, pp 337–346 | Cite as

Long chain omega-3 fatty acids intake, fish consumption and mental disorders in the SUN cohort study

  • Almudena Sanchez-Villegas
  • Patricia Henríquez
  • Adolfo Figueiras
  • Felipe Ortuño
  • Francisca Lahortiga
  • Miguel A. Martínez-González
ORIGINAL CONTRIBUTION

Abstract

Background

Very long chain omega-3 fatty acids (w-3 PUFA) intake and fish consumption have been suggested as protective factors against neuropsychiatric disorders but there is scarcity of large cohort studies assessing this association.

Aim of the study

To assess the association between w-3-PUFA intake and fish consumption and mental disorders.

Methods

A prospective cohort study was performed in 7,903 participants. W-3 PUFA intake and fish consumption were ascertained through a validated semi-quantitative food frequency questionnaire. The outcomes after 2 years of follow-up were: (1) Incident mental disorder (depression, anxiety, or stress), (2) incident depression, and (3) incident anxiety. Logistic regression models and generalized additive models were fit to assess the relationship between w-3 PUFA intake or fish consumption and the incidence of these outcomes. Odds ratios (OR) and their 95% confidence intervals (CI) were calculated.

Results

173 cases of depression, 335 cases of anxiety, and 4 cases of stress were observed during 2-year follow-up. ORs (95% CI) of mental disorder for successive quintiles of energy-adjusted w-3 PUFA intake were 1 (reference), 0.72 (0.52–0.99), 0.79 (0.58–1.08), 0.65 (0.47–0.90), and 1.04 (0.78–1.40). Subjects with a moderate consumption of fish (third and fourth quintiles of consumption: median of each quintile 83.3 and 112 g/day, respectively) had a relative risk reduction higher than 30%.

Conclusions

A potential benefit of w-3 PUFA intake on total mental disorders is suggested, although no linear trend was apparent.

Keywords

omega-3 fatty acids fish depression anxiety mental disorder 

Notes

Acknowledgments

We are indebted to the participants of the SUN Study for their continued cooperation and participation. We thank other members of the SUN Group: M. Seguí-Gómez, C. de la Fuente, J. de Irala, A. Alonso, M. Delgado-Rodríguez, M. Serrano-Martínez, J.A. Martínez, Ll Serra-Majem and J. Doreste. The Spanish Ministry of Health (Fondo de Investigaciones Sanitarias, Projects PI 042241, PI040233, & PI050976) and the Navarra Regional Government (PI41/2005) are acknowledged for supporting the study.

References

  1. 1.
    Bates CJ, Prentice A, Birch MC, Delves HT, Sinclair KA (2006) Blood indices of selenium and mercury, and their correlations with fish intake, in young people living in Britain. Br J Nutr 96:523–531Google Scholar
  2. 2.
    Baylin A, Kabagambe EK, Siles X, Campos H (2002) Adipose tissue biomarkers of fatty acid intake. Am J Clin Nutr 76:750–757Google Scholar
  3. 3.
    Chasan-Taber S, Rimm EB, Stampfer MJ, Spiegelman D, Colditz GA, Giovannucci E, Ascherio A, Willet WC (1996) Reproducibility and validity of a self-administered physical activity questionnaire for male health professionals. Epidemiology 7:81–86CrossRefGoogle Scholar
  4. 4.
    Crow S, Eisenberg ME, Story M, Neumark-Sztainer D (2006) Psychosocial and behavioural correlates of dieting among overweight and non-overweight adolescents. J Adolesc Health 38:569–574CrossRefGoogle Scholar
  5. 5.
    De Vriese SR, Christophe AB, Maes M (2003) Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurrence of postpartum depression: further evidence that lowered n-PUFAs are related to major depression. Life Sci 73:3181–3187CrossRefGoogle Scholar
  6. 6.
    Din JN, Newby DE, Flapan AD (2004) Omega 3 fatty acids and cardiovascular disease – fishing for a natural treatment. BMJ 328:30–35CrossRefGoogle Scholar
  7. 7.
    Edwards R, Peet M, Shay J, Horrobin D (1998) Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord 48:149–155CrossRefGoogle Scholar
  8. 8.
    Ellis FR, Sanders TA (1977) Long chain polyunsaturated fatty acids in endogenous depression. J Neurol Neurosurg Psychiatry 40:168–169CrossRefGoogle Scholar
  9. 9.
    Emsley R, Myburgh C, Oosthuizen P, van Rensburg SJ (2002) Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia. Am J Psychiatry 159:1596–1598CrossRefGoogle Scholar
  10. 10.
    Falco G, Llobet JM, Bocio A, Domingo JL (2006) Daily intake of arsenic, cadmium, mercury, and lead by consumption of edible marine species. J Agric Food Chem 54:6106–6112CrossRefGoogle Scholar
  11. 11.
    Fehily AMA, Bowey AM, Ellis FR, Meade BW, Dickerson JWT (1981) Plasma and erythrocyte membrane long chain polyunsaturated fatty acids in endogenous depression. Neurochem Int 3:37–42CrossRefGoogle Scholar
  12. 12.
    Fernstrom JD (1999) Effects of dietary polyunsaturated fatty acids in neuronal function. Lipids 34:161–169CrossRefGoogle Scholar
  13. 13.
    Feskanich D, Rimm EB, Giovannucci EL, Colditz GA, Stampfer MJ, Litin LB, Willett WC (1993) Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc 93:790–796CrossRefGoogle Scholar
  14. 14.
    Figueiras A, Cadarso-Suárez C (2001) Application of nonparametric models for calculating odds ratios and their confidence intervals in continuous exposures. Am J Epidemiol 154:264–275CrossRefGoogle Scholar
  15. 15.
    Fontani G, Corradeschi F, Felici A, Alfatti F, Migliorini S, Lodi L (2005) Cognitive and physiological effects of omega-3 polyunsaturated fatty acid supplementation in healthy subjects. Eur J Clin Invest 35:691–699CrossRefGoogle Scholar
  16. 16.
    Frangou S, Lewis M, McCrone P (2006) Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study. Br J Psychiatry 188:46–50CrossRefGoogle Scholar
  17. 17.
    Frasure-Smith N, Lesperance F, Julien P (2004) Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes. Biol Psychiatry 55:891–896CrossRefGoogle Scholar
  18. 18.
    Freeman MP, Hibbeln JR, Wisner KL, Brumbach BH, Watchman M, Gelenberg AJ (2006) Supplementation with omega-3 fatty acids may help reduce postpartum depression. Acta Psychiatr Scand 113:31–35CrossRefGoogle Scholar
  19. 19.
    Green P, Hermesh H, Monselise A, Marom S, Presburger G, Weizman A (2006) Red cell membrane omega-3 fatty acids are decreased in nondepressed patients with social anxiety disorder. Eur Neuropsychopharmacol 16:107–113CrossRefGoogle Scholar
  20. 20.
    Greenland S (1995) Avoiding power loss associated with categorization and ordinal scores in dose-response and trend analysis. Epidemiology 6:450–454CrossRefGoogle Scholar
  21. 21.
    Hakkarainen R, Partonen T, Haukka J, Virtamo J, Albanes D, Lonnqvist J (2004) Is low dietary intake of omega-3 fatty acids associated with depression? Am J Psychiatry 161:567–569CrossRefGoogle Scholar
  22. 22.
    Hibbeln JR (1998) Fish consumption and major depression. Lancet 351:1213CrossRefGoogle Scholar
  23. 23.
    Hibbeln JR (2002) Seafood consumption, the DHA content of mothers’ milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. J Affect Disord 69:15–29CrossRefGoogle Scholar
  24. 24.
    Hock C, Drasch G, Golombowski S, Muller-Spahn F, Willershausen-Zonnchen B, Schwarz P, Hock U, Growdon JH, Nitsch RM (1998) Increased blood mercury levels in patients with Alzheimer’s disease. J Neural Transm 105:59–68CrossRefGoogle Scholar
  25. 25.
    Hunter DJ, Rimm EB, Sacks FM, Stampfer MJ, Colditz GA, Litin LB, Willett WC (1992) Comparison of measures of fatty acid intake by subcutaneous fat aspirate, food frequency questionnaire, and diet records in a free-living population of US men. Am J Epidemiol 135:418–427Google Scholar
  26. 26.
    Iribarren C, Markovitz JH, Jacobs DR Jr, Schreiner PJ, Daviglus M, Hibbeln JR (2004) Dietary intake of n-3, n-6 fatty acids and fish: relationship with hostility in young adults—the CARDIA study. Eur J Clin Nutr 58:24–31CrossRefGoogle Scholar
  27. 27.
    Kris-Etherton PM, Harris WS, Appel LJ; American Heart Association, Nutrition Committee (2003) Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Arterioscler Thromb Vasc Biol 23:e20–30CrossRefGoogle Scholar
  28. 28.
    Lindeman M, Stark K (1999) Pleasure, pursuit of health or negotiation of identity? Personality correlates of food choices motives among young and middle-aged women. Appetite 33:141–161CrossRefGoogle Scholar
  29. 29.
    Lindeman M, Stark K (2000) Loss of pleasure, ideological food choice reasons and eating pathology. Appetite 35:263–268CrossRefGoogle Scholar
  30. 30.
    Logan AC (2003) Neurobehavioral aspects of omega-3 fatty acids: possible mechanisms and therapeutic value in major depression. Altern Med Rev 8:410–425Google Scholar
  31. 31.
    Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ (2006) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367:1747–1757CrossRefGoogle Scholar
  32. 32.
    Lowe B, Spitzer RL, Grafe K, Kroenke K, Quenter A, Zipfel S, Buchholz C, Witte S, Herzog W (2004) Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians’ diagnoses. J Affect Disord 78:131–140CrossRefGoogle Scholar
  33. 33.
    Maes M, Christophe A, Delanghe J, Altamura C, Neels H, Meltzer HY (1999) Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res 85:275–291CrossRefGoogle Scholar
  34. 34.
    Maes M, Smith R, Christophe A, Cosyns P, Desnyder R, Meltzer H (1996) Fatty acid composition in major depression: decreased omega 3 fractions in cholesteryl esters and increased C20: 4 omega 6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids. J Affect Disord 38:35–46CrossRefGoogle Scholar
  35. 35.
    Martin-Moreno JM, Boyle P, Gorgojo L, Maisonneuve P, Fernandez-Rodriguez JC, Salvini S, Willett WC (1993) Development and validation of a food frequency questionnaire in Spain. Int J Epidemiol 22:512–519CrossRefGoogle Scholar
  36. 36.
    Martinez-Gonzalez MA, Sanchez-Villegas A, De IJ, Marti A, Martinez JA (2002) Mediterranean diet and stroke: objectives and design of the SUN project. Seguimiento Universidad de Navarra. Nutr Neurosci 5:65–73CrossRefGoogle Scholar
  37. 37.
    Mataix J (2003) Tabla de composición de alimentos [Food composition tables], 4th edn. Universidad de Granada, Granada (in Spanish)Google Scholar
  38. 38.
    Miller GE, Stetler CA, Carney RM, Freedland KE, Banks WA (2002) Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol 90:1279–1283CrossRefGoogle Scholar
  39. 39.
    Moreiras O (2003) Tablas de composición de alimentos [Food composition tables], 7th edn. Ediciones Madrid Pirámide, Madrid (in Spanish)Google Scholar
  40. 40.
    Murray CJ, Lopez AD (1997) Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 349:1498–1504CrossRefGoogle Scholar
  41. 41.
    Nemets H, Nemets B, Apter A, Bracha Z, Belmaker RH (2006) Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. Am J Psychiatry 163:1098–1100CrossRefGoogle Scholar
  42. 42.
    Nemets B, Stahl Z, Belmaker RH (2002) Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 159:477–479CrossRefGoogle Scholar
  43. 43.
    Otto SJ, de Groot RH, Hornstra G (2003) Increased risk of postpartum depressive symptoms is associated with slower normalization after pregnancy of the functional docosahexaenoic acid status. Prostaglandins Leukot Essent Fatty Acids 69:237–243CrossRefGoogle Scholar
  44. 44.
    Parker GB, Heruc GA, Hilton TM, Olley A, Brotchie H, Hadzi-Pavlovic D, Friend C, Walsh WF, Stocker R (2006) Low levels of docosahexaenoic acid identified in acute coronary syndrome patients with depression. Psychiatry Res 141:279–286CrossRefGoogle Scholar
  45. 45.
    Peet M, Horrobin DF (2002) A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 59:913–919CrossRefGoogle Scholar
  46. 46.
    Peet M, Murphy B, Shay J, Horrobin D (1998) Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 43:315–319CrossRefGoogle Scholar
  47. 47.
    Rees JR, Sturup S, Chen C, Folt C, Karagas MR (2007) Toenail mercury and dietary fish consumption. J Expo Sci Environ Epidemiol 17:25CrossRefGoogle Scholar
  48. 48.
    Salvini S, Hunter DJ, Sampson L, Stampfer MJ, Colditz GA, Rosner B, Willett WC (1989) Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol 18:858–867CrossRefGoogle Scholar
  49. 49.
    Sanzo JM, Dorronsoro M, Amiano P, Amurrio A, Aguinagalde FX, Azpiri MA, EPIC Group of Spain [European Prospective Investigation into Cancer, Nutrition] (2001) Estimation and validation of mercury intake associated with fish consumption in an EPIC cohort of Spain. Public Health Nutr 4:981–988CrossRefGoogle Scholar
  50. 50.
    Sontrop J, Campbell MK (2006) Omega-3 polyunsaturated fatty acids and depression: a review of the evidence and a methodological critique. Prev Med 42:4–13CrossRefGoogle Scholar
  51. 51.
    Tanskanen A, Hibbeln JR, Tuomilehto J, Uutela A, Haukkala A, Viinamaki H, Lehtonen J, Vartiainen E (2001) Fish consumption and depressive symptoms in the general population in Finland. Psychiatr Serv 52:529–531CrossRefGoogle Scholar
  52. 52.
    Tiemeier H, van Tuijl HR, Hofman A, Kiliaan AJ, Breteler MM (2003) Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study. Am J Clin Nutr 78:40–46Google Scholar
  53. 53.
    Timonen M, Horrobin D, Jokelainen J, Laitinen J, Herva A, Rasanen P (2004) Fish consumption and depression: the Northern Finland 1966 birth cohort study. J Affect Disord 82:447–452Google Scholar
  54. 54.
    Willett WC, Stampfer M (1998) Implications of total energy intake for epidemiologic analyses. In: Willett WC (ed) Nutritional epidemiology, 2nd edn. Oxford University Press, New York, pp 273–301Google Scholar
  55. 55.
    Wojcik DP, Godfrey ME, Christie D, Haley BE (2006) Mercury toxicity presenting as chronic fatigue, memory impairment and depression: diagnosis, treatment, susceptibility, and outcomes in a New Zealand general practice setting (1994–2006). Neuro Endocrinol Lett 27:4Google Scholar

Copyright information

© Spinger 2007

Authors and Affiliations

  • Almudena Sanchez-Villegas
    • 1
    • 2
  • Patricia Henríquez
    • 3
  • Adolfo Figueiras
    • 4
  • Felipe Ortuño
    • 5
  • Francisca Lahortiga
    • 5
  • Miguel A. Martínez-González
    • 2
  1. 1.Dept. of Clinical SciencesUniversity of Las Palmas de Gran CanariaLas Palmas de Gran CanariaSpain
  2. 2.Dept. of Preventive Medicine and Public HealthUniversity of NavarraPamplonaSpain
  3. 3.Dept. of NursingUniversity of Las Palmas de Gran CanariaLas Palmas de Gran CanariaSpain
  4. 4.Dept. of Preventive Medicine and Public Health (AF)University of Santiago de CompostelaSantiago de CompostelaSpain
  5. 5.Dept. of PsychiatryUniversity of NavarraPamplonaSpain

Personalised recommendations